Index S&P 500
P/E 27.88
EPS (ttm) 2.37
Insider Own 0.90%
Shs Outstand 222.84M
Perf Week 1.86%
Market Cap 14.72B
Forward P/E 14.66
EPS next Y 4.51
Insider Trans 0.27%
Shs Float 220.85M
Perf Month 6.22%
Enterprise Value 15.63B
PEG 4.06
EPS next Q 1.05
Inst Own 102.08%
Short Float 2.28%
Perf Quarter 6.90%
Income 556.70M
P/S 3.65
EPS this Y 2.51%
Inst Trans -2.26%
Short Ratio 1.38
Perf Half Y -9.19%
Sales 4.03B
P/B 3.19
EPS next Y 7.73%
ROA 6.45%
Short Interest 5.03M
Perf YTD -8.40%
Book/sh 20.73
P/C 9.08
EPS next 5Y 6.86%
ROE 11.77%
52W High 84.67 -22.01%
Perf Year -11.02%
Cash/sh 7.27
P/FCF 14.78
EPS past 3/5Y -22.74% -
ROIC 7.85%
52W Low 51.90 27.23%
Perf 3Y -6.90%
Dividend Est. -
EV/EBITDA 12.48
Sales past 3/5Y -10.56% 3.66%
Gross Margin 55.98%
Volatility 2.06% 2.06%
Perf 5Y 23.04%
Dividend TTM -
EV/Sales 3.88
EPS Y/Y TTM 21.95%
Oper. Margin 23.72%
ATR (14) 1.55
Perf 10Y 74.10%
Dividend Ex-Date -
Quick Ratio 2.52
Sales Y/Y TTM 1.66%
Profit Margin 13.83%
RSI (14) 65.62
Recom 2.50
Dividend Gr. 3/5Y - -
Current Ratio 3.24
EPS Q/Q -110.78%
SMA20 2.39%
Beta 0.55
Target Price 66.93
Payout 0.00%
Debt/Eq 0.55
Sales Q/Q -1.23%
SMA50 9.58%
Rel Volume 0.30
Prev Close 65.16
Employees 7063
LT Debt/Eq 0.54
Earnings May 01 AMC
SMA200 -4.40%
Avg Volume 3.64M
Price 66.03
IPO Mar 01, 1990
Option/Short Yes / Yes
EPS/Sales Surpr. 1.37% 0.48%
Trades
Volume 571,207
Change 1.34%
Date
Action
Analyst
Rating Change
Price Target Change
May-27-25 Reiterated
Needham
Hold
Mar-03-25 Downgrade
Argus
Buy → Hold
Feb-06-25 Downgrade
Leerink Partners
Outperform → Market Perform
$80 → $75
Feb-03-25 Downgrade
Needham
Buy → Hold
Dec-13-24 Initiated
Wolfe Research
Peer Perform
Dec-10-24 Reiterated
Needham
Buy
$90
Dec-10-24 Initiated
Jefferies
Hold
$85
Oct-01-24 Downgrade
Citigroup
Buy → Neutral
$95 → $85
Jun-27-24 Initiated
Stephens
Overweight
$87
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Show Previous Ratings
Jun-26-25 05:45PM
04:08AM
Jun-25-25 09:13AM
Jun-23-25 09:32AM
09:00AM
06:41AM
Loading…
Jun-20-25 06:41AM
Jun-17-25 05:45PM
Jun-16-25 08:30AM
Jun-11-25 08:29AM
Jun-10-25 08:04PM
09:00AM
Jun-09-25 08:42AM
Jun-04-25 08:41AM
May-30-25 09:00AM
May-28-25 05:16PM
04:29AM
Loading…
04:29AM
May-27-25 11:35PM
05:22PM
04:07PM
02:04PM
08:24AM
May-22-25 05:05PM
May-21-25 12:01AM
May-19-25 09:00AM
May-15-25 04:46PM
May-13-25 04:10PM
09:16AM
May-12-25 08:44AM
May-07-25 12:16PM
May-06-25 09:00AM
12:32AM
Loading…
12:32AM
May-02-25 02:25PM
(Morningstar Research) -5.45%
11:57AM
10:11AM
(Thomson Reuters StreetEvents)
07:25AM
03:15AM
May-01-25 08:24PM
05:30PM
05:10PM
04:17PM
(Associated Press Finance)
04:01PM
Apr-30-25 05:50PM
09:31AM
Apr-28-25 09:15AM
08:45AM
Apr-25-25 08:18AM
Apr-24-25 08:10AM
Apr-23-25 09:00AM
Apr-22-25 10:10AM
09:03AM
08:08AM
Apr-21-25 05:45PM
Apr-14-25 05:45PM
Apr-11-25 09:00AM
Apr-10-25 05:14AM
Apr-07-25 05:45PM
08:48AM
Apr-04-25 04:15PM
Apr-03-25 04:30PM
09:40AM
Mar-31-25 05:45PM
09:00AM
Mar-24-25 05:45PM
Mar-20-25 11:46AM
Mar-19-25 09:57AM
09:00AM
Mar-17-25 05:45PM
Mar-13-25 06:58PM
Mar-10-25 05:01AM
Mar-07-25 11:30AM
09:00AM
Mar-04-25 07:37AM
Feb-26-25 04:01AM
Feb-25-25 08:15AM
Feb-24-25 09:00AM
Feb-21-25 12:28PM
08:30AM
Feb-20-25 05:23AM
03:00AM
Feb-19-25 05:16AM
Feb-18-25 08:08AM
Feb-12-25 08:08AM
Feb-11-25 09:15AM
09:00AM
08:12AM
Feb-07-25 09:40AM
07:21AM
Feb-06-25 09:50AM
09:34AM
08:05AM
(Thomson Reuters StreetEvents)
02:13AM
Feb-05-25 05:30PM
05:15PM
04:11PM
(Associated Press Finance)
04:11PM
04:01PM
Feb-04-25 09:40AM
Jan-31-25 09:15AM
09:00AM
Jan-29-25 10:01AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Madaus Martin D Director May 07 '25 Buy 55.24 5,445 300,760 5,445 May 09 04:39 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Option Exercise 62.60 22,902 1,433,659 52,813 Dec 06 04:28 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Sale 76.34 24,856 1,897,482 27,957 Dec 06 04:28 PM Mitchell Essex D Officer Dec 04 '24 Proposed Sale 76.34 24,856 1,897,484 Dec 04 12:24 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Option Exercise 40.95 32,805 1,343,214 136,721 Sep 03 04:15 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Sale 80.56 52,679 4,243,662 84,042 Sep 03 04:15 PM Oberton Karleen Marie Officer Aug 29 '24 Proposed Sale 80.56 52,679 4,243,657 Aug 29 04:36 PM Schnittker Brandon Div. President, GYN Surgical Aug 06 '24 Sale 83.11 476 39,559 3,735 Aug 08 04:08 PM Schnittker Brandon Officer Aug 06 '24 Proposed Sale 83.11 476 39,559 Aug 06 04:48 PM COHN BENJAMIN JORDAN Principal Accounting Officer Aug 01 '24 Sale 81.99 5,093 417,570 10,476 Aug 05 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Option Exercise 26.21 44,039 1,154,262 1,201,601 Aug 01 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Sale 81.70 44,039 3,597,924 1,157,562 Aug 01 04:09 PM COHN BENJAMIN JORDAN Officer Aug 01 '24 Proposed Sale 81.99 5,093 417,574 Aug 01 03:58 PM MACMILLAN STEPHEN P Officer Jul 30 '24 Proposed Sale 81.70 44,039 3,597,894 Jul 30 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Option Exercise 26.21 3,672 96,243 1,161,234 Jul 19 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Sale 80.13 3,672 294,223 1,157,562 Jul 19 04:09 PM Stamoulis Christiana Director Jul 17 '24 Option Exercise 26.74 9,039 241,703 54,511 Jul 19 04:06 PM Stamoulis Christiana Director Jul 17 '24 Sale 79.50 9,039 718,600 45,472 Jul 19 04:06 PM